Large-scale testing (Phase 3)Ended earlyNCT00333216What this trial is testingAnecortave Acetate Risk-Reduction Trial (AART)Who this might be right forAMD Alcon Research 24
Early research (Phase 1)Study completedNCT03748784What this trial is testingADVM-022 Intravitreal Gene Therapy for Wet AMDWho this might be right forWet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration Adverum Biotechnologies, Inc. 30
Large-scale testing (Phase 3)Study completedNCT03034772What this trial is testingDorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular DegenerationWet Macular Degeneration Wills Eye 52
Large-scale testing (Phase 3)Study completedNCT02157077What this trial is testingAflibercept After Ranibizumab in Exudative Age-related Macular DegenerationWho this might be right forMacular DegenerationWet Macular DegenerationRetinal Degeneration+2 more Centre Hospitalier Intercommunal Creteil 90
Large-scale testing (Phase 3)Study completedNCT03844074What this trial is testingA Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)Who this might be right forAge-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration Outlook Therapeutics, Inc. 61
Post-approval studies (Phase 4)Study completedNCT01775124What this trial is testingEfficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)Who this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 332
Testing effectiveness (Phase 2)Looking for participantsNCT04504123What this trial is testingMMP-9 Inhibition for Recalcitrant Wet AMDWho this might be right forExudative Macular DegenerationWet Age-related Macular Degeneration University of Iowa 50
Testing effectiveness (Phase 2)Study completedNCT00605423What this trial is testingThe MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) PilotWho this might be right forAge Related Macular Degeneration Johns Hopkins University 6
Not applicableStudy completedNCT00088192What this trial is testingIntravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)Who this might be right forMacular Degeneration Eyetech Pharmaceuticals
Not applicableStudy completedNCT00531141What this trial is testingThe Optical Coherence Tomography in Age-Related Macular Degeneration Study: The OCT in AMD StudyWho this might be right forMacular Degeneration The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 200
Testing effectiveness (Phase 2)Study completedNCT00413829What this trial is testingImmediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)Who this might be right forAge Related Macular Degeneration Insel Gruppe AG, University Hospital Bern 20
Testing effectiveness (Phase 2)Study completedNCT04832724What this trial is testingRGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)Who this might be right forNeovascular Age-related Macular DegenerationWet Macular DegenerationWet Age-related Macular Degeneration AbbVie 60
Not applicableActive Not RecruitingNCT04420923What this trial is testingOptimizing the Treatment Strategy for Age-related Macular DegenerationWho this might be right forWet Macular Degeneration St. Olavs Hospital 250
Post-approval studies (Phase 4)Study completedNCT01810042What this trial is testingIndocyanine Angiographic Changes of Choroidal Neovascularization by RanibizumabWho this might be right forExudative Age-related Macular Degeneration Pusan National University Hospital 49
Not applicableNot Yet RecruitingNCT07340372What this trial is testingHome Monitoring in eAMD TreatmentWho this might be right forExudative Age-Related Macular Degeneration Association for Innovation and Biomedical Research on Light and Image 80
Not applicableStudy completedNCT02321241What this trial is testingReal Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMDWho this might be right forWet Macular Degeneration Bayer 236
Large-scale testing (Phase 3)Study completedNCT04597632What this trial is testingAn Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) StudyWho this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 248
Testing effectiveness (Phase 2)Study completedNCT01157065What this trial is testingEvaluation of AL-78898A in Exudative Age-Related Macular DegenerationWho this might be right forExudative Age-Related Macular Degeneration Alcon Research 99
Not applicableActive Not RecruitingNCT04645212What this trial is testingLong-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]Who this might be right forWet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration Adverum Biotechnologies, Inc. 23
Not applicableStudy completedNCT03803631What this trial is testingCNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)Who this might be right forAMDExudative Macular Degeneration Centre Hospitalier Intercommunal Creteil 49